Apolipoprotein E and neuromuscular disease: a critical review of the literature.

Molecular mechanisms that alter the incidence and rate of neuromuscular disease progression are, in many cases, only partially understood. Several recent studies have asked whether apolipoprotein E (apoE for the protein, APOE for the gene) influences these aspects of specific neuromuscular disorders, as it does in central nervous system disorders such as Alzheimer disease. Although these studies are open to methodological criticism, several interesting trends have emerged. First, the APOE4 allele seems to be associated with an increased risk for developing certain neuromuscular diseases, including diabetic neuropathy and human immunodeficiency viral neuropathy. Second, this allele appears to be associated with faster progression of some neuromuscular diseases, including diabetic neuropathy and possibly motor neuron disease. Third, the APOE2 allele seems to confer protection against developing certain neuromuscular diseases, including the amyotrophic lateral sclerosis (ALS)/parkinsonism/dementia complex of Guam. Finally, this allele is associated with a better prognosis in neuromuscular diseases such as motor neuron disease. The effect of various APOE alleles on neuromuscular diseases therefore parallels their influence on central nervous system diseases. Arch Neurol. 2000;57:1561-1565

[1]  W. Strittmatter,et al.  Apolipoprotein E Binds to and Potentiates the Biological Activity of Ciliary Neurotrophic Factor , 1997, The Journal of Neuroscience.

[2]  E. Shooter,et al.  Denervated sheath cells secrete a new protein after nerve injury. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A D Roses,et al.  Apolipoprotein E and Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  W. White,et al.  Predictors of cognitive decline after cardiac operation. , 1995, The Annals of thoracic surgery.

[5]  J. Taylor,et al.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.

[6]  W. Strittmatter,et al.  ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.

[7]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[8]  M. Nelson,et al.  Peripheral neuropathy in HIV , 1997, International journal of STD & AIDS.

[9]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[11]  S. Thibodeau,et al.  Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex , 1994, The Lancet.

[12]  M. Pericak-Vance,et al.  Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases , 1993, The Lancet.

[13]  P. Hof,et al.  Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/ parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes , 1996, Acta Neuropathologica.

[14]  D. Arveiler,et al.  Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  A. Roses,et al.  Apolipoprotein E Is Localized to the Cytoplasm of Human Cortical Neurons: A Light and Electron Microscopic Study , 1994, Journal of neuropathology and experimental neurology.

[16]  P. Wilson,et al.  Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. , 1987, Journal of lipid research.

[17]  L. Haverkamp,et al.  Apolipoprotein E ɛ4 in bulbar-onset motor neuron disease , 1996, The Lancet.

[18]  W. White,et al.  Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. , 1997, The Annals of thoracic surgery.

[19]  W. Strittmatter,et al.  Interaction of Apolipoprotein E with Laminin Increases Neuronal Adhesion and Alters Neurite Morphology , 1995, Experimental Neurology.

[20]  P. Froguel,et al.  Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.

[21]  C. Harrington,et al.  Apolipoprotein E type epsilon 4 allele frequency is not increased in patients with sporadic inclusion-body myositis. , 1995, Neuroscience letters.

[22]  T. Murano,et al.  [The examination of apoE phenotypes in diabetic patients with peripheral neuropathy]. , 1998, Rinsho byori. The Japanese journal of clinical pathology.

[23]  A. Malafosse,et al.  Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis , 1996, Journal of the Neurological Sciences.

[24]  Lars Lannfelt,et al.  HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy , 1998, Nature Medicine.

[25]  W. Mobley,et al.  Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  S. Wilton,et al.  Apolipoprotein E and Alzheimer's disease , 1995 .

[27]  Robert H. Brown,et al.  Apolipoprotein E ϵ4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis , 1995 .

[28]  P. Sham,et al.  Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. , 1996, Lancet.

[29]  S. Fullerton,et al.  Peripheral Sensory Nerve Defects in Apolipoprotein E Knockout Mice , 1998, Experimental Neurology.

[30]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[31]  R. Mahley,et al.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. , 1987, Biochimica et biophysica acta.

[32]  L. Kurland,et al.  Amyotrophic lateral sclerosis and parkinson's disease complex on Guam linked to an environmental neurotoxin , 1988, Trends in Neurosciences.

[33]  D. Holtzman,et al.  Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Shooter,et al.  A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. , 1985, Science.

[35]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[36]  G. Murray,et al.  Association of apolipoprotein E polymorphism with outcome after head injury , 1997, The Lancet.

[37]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[38]  N. Maeda,et al.  Nerve Regeneration Occurs in the Absence of Apolipoprotein E in Mice , 1993, Journal of neurochemistry.

[39]  N. Relkin,et al.  Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. , 1997, JAMA.

[40]  S H Appel,et al.  Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. , 1995, Brain : a journal of neurology.

[41]  J. Powell,et al.  Association of apolipoprotein E ∈4 allele with bulbar-onset motor neuron disease , 1996, The Lancet.

[42]  R. Mahley,et al.  Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.

[43]  Jonathan D. Smith,et al.  Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.